CD34+ fibrocytes in chronic cystitis and noninvasive and invasive urothelial carcinomas of the urinary bladder

Virchows Archiv

Volumn 450, Issue 2, 2007, Pages 179-185

  Nimphius, Wilhelm ^a   Moll, Roland ^a   Olbert, Peter ^a   Ramaswamy, Annette ^a   Barth, Peter J ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

CD34; Fibrocyte; Stroma; Urinary bladder; Urothelial carcinoma

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; OSTEONECTIN; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CARCINOMA IN SITU; CD34 SELECTION; CELL LOSS; CONTROLLED STUDY; CYSTITIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INVASIVE CARCINOMA; LAMINA PROPRIA; MAJOR CLINICAL STUDY; MALE; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA; UROGENITAL TRACT TUMOR;

ACTINS; ADAM PROTEINS; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; CHRONIC DISEASE; CONNECTIVE TISSUE CELLS; CYSTITIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-KIT; STROMAL CELLS; URINARY BLADDER NEOPLASMS;

EID: 33847124876     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-006-0347-6     Document Type: Article

References (27)

1. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN (2001) Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 166:7556-7562
2. Abe K, Hibino T, Mishima H, Shimomura Y (2004) The cytokine regulation of SPARC production by rabbit corneal epithelial cells and fibroblasts in vitro. Cornea 23:172-179
3. + fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions. Virchows Arch 440:298-303
4. + fibrocytes in neoplastic and inflammatory pancreatic lesions. Virchows Arch 440:128-133
5. + fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III, and invasive squamous cell carcinoma of the cervix uteri. Virchows Arch 441:564-568
6. + fibrocytes, α-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx. Virchows Arch 444:231-234
7. + fibrocytes in normal mitral valves and myxomatous mitral valve degeneration. Pathol Res Pract 201:301-304
8. Barth PJ, Moll R, Ramaswamy A (2005) Stromal remodeling and SPARC (secreted protein acid rich in cysteine) expression in invasive ductal carcinomas of the breast. Virchows Arch 446:532-536
9. Bradshaw AD, Sage EH (2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107:1049-1054
10. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1:71-81
11. Chauhan H, Abraham A, Phillips JR, Pringle JH, Walker RA, Jones JL (2003) There is more than one kind of myofibroblast: analysis of CD34 expression in benign, in situ, and invasive breast lesions. J Clin Pathol 56:271-276
12. Chesney J, Bacher M, Bender A, Bucala R (1997) The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ. Proc Natl Acad Sci USA 94:6307-6312
13. Chesney J, Metz C, Stavitsky AB, Bacher M, Bucala R (1998) Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 160:419-425
14. Espana EM, Kawakita T, Liu CY, Tseng SC (2004) CD-34 expression by cultured human keratocytes is downregulated during myofibroblast differentiation induced by TGF-beta1. Invest Ophthalmol Vis Sci 45:2985-2991
15. Framson PE, Sage EH (2004) SPARC and tumor growth: where the seed meets the soil? J Cell Biochem 92:679-690
16. Hartlapp I, Abe R, Saeed RW, Peng T, Voelter W, Bucala R, Metz CN (2001) Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J 15:2215-2224
17. Iacobuzio-Donahue CA, Argani P, Hempen PM, Jones J, Kern SE (2002) The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types. Cancer Res 62:5351-5357
18. Majdic O, Stockl J, Pickl WF, Bohuslav J, Strobl H, Scheinecker C, Stockinger H, Knapp W (1994) Signaling and induction of enhanced cytoadhesiveness via the hematopoietic progenitor cell surface molecule CD34. Blood 83:1226-1234
19. Murphy-Ullrich JE (2001) The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J Clin Invest 107:785-790
20. Nakayama H, Enzan H, Miyazaki E, Kuroda N, Naruse K, Hiroi M (2000) Differential expression of CD34 in normal colorectal tissue, peritumoral inflammatory tissue, and tumour stroma. J Clin Pathol 53:626-629
21. Nakayama H, Enzan H, Miyazaki E, Kuroda N, Naruse K, Kiyoku H, Toi M, Hiroi M (2001) CD34 positive stromal cells in gastric adenocarcinomas. J Clin Pathol 54:846-848
22. Nakayama H, Enzan H, Yamamoto M, Miyazaki E, Hidaka C, Okumichi T, Okumichi A, KajiharaH (2003) CD34-positive stromal cells in primary lung carcinomas. Oncol Rep 10:1313-1316
23. Porter PL, Sage EH, Lane TF, Funk SE, Gown AM (1995) Distribution of SPARC in normal and neoplastic human tissue. J Histochem Cytochem 43:791-800
24. + fibrocytes in tubular carcinomas and radial scars of the breast. Virchows Arch 443:536-540
25. Reed MJ, Vernon RB, Abrass IB, Sage EH (1994) TGF-beta 1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors. J Cell Physiol 158:169-179 26. Ryu B, Jones J, Hollingsworth MA, Hruban RH, Kern SE (2001) Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers. Cancer Res 61:1833-1838
26. Schiemann BJ, Neil JR, Schiemann WP (2003) SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-?-signaling system. Mol Biol Cell 14:3977-3988
27. Shimasaki N, Kuroda N, Miyazaki E, Hayashi Y, Toi M, Hiroi M, Enzan H, Shuin T (2006) The distribution pattern of myofibroblasts in the stroma of human bladder carcinoma depends on their invasiveness. Histol Histopathol 21:349-353